A detailed history of Susquehanna International Group, LLP transactions in Illumina, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 119,535 shares of ILMN stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,535
Previous 60,626 97.17%
Holding current value
$15.4 Million
Previous $8.33 Million 49.87%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$101.05 - $133.57 $5.95 Million - $7.87 Million
58,909 Added 97.17%
119,535 $12.5 Million
Q1 2024

May 07, 2024

SELL
$127.73 - $147.2 $17.5 Million - $20.2 Million
-136,997 Reduced 69.32%
60,626 $8.33 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $11.7 Million - $18 Million
126,189 Added 176.65%
197,623 $27.5 Million
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $3.59 Million - $5.36 Million
27,843 Added 63.87%
71,434 $9.81 Million
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $25.5 Million - $32.4 Million
-139,209 Reduced 76.15%
43,591 $8.17 Million
Q1 2023

May 16, 2023

BUY
$193.75 - $232.55 $5.31 Million - $6.38 Million
27,432 Added 17.66%
182,800 $42.5 Million
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $2.04 Million - $2.65 Million
10,913 Added 7.55%
155,368 $31.4 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $9.1 Million - $11.7 Million
51,363 Added 55.17%
144,455 $27.6 Million
Q2 2022

Aug 15, 2022

SELL
$181.58 - $368.0 $12.6 Million - $25.4 Million
-69,132 Reduced 42.62%
93,092 $17.2 Million
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $6.69 Million - $9.34 Million
22,031 Added 15.71%
162,224 $56.7 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $13 Million - $15.8 Million
37,523 Added 36.55%
140,193 $53.3 Million
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $2.81 Million - $3.63 Million
-6,924 Reduced 6.32%
102,670 $41.6 Million
Q2 2021

Aug 11, 2021

BUY
$372.84 - $481.5 $3.23 Million - $4.17 Million
8,662 Added 8.58%
109,594 $51.9 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $23.8 Million - $33.2 Million
65,836 Added 187.59%
100,932 $38.8 Million
Q4 2020

Feb 16, 2021

SELL
$292.7 - $370.96 $29 Million - $36.7 Million
-99,024 Reduced 73.83%
35,096 $13 Million
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $6.46 Million - $9.65 Million
24,071 Added 21.87%
134,120 $41.5 Million
Q2 2020

Aug 14, 2020

SELL
$256.46 - $373.01 $4.36 Million - $6.35 Million
-17,018 Reduced 13.39%
110,049 $40.8 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $3.97 Million - $6.37 Million
18,983 Added 17.56%
127,067 $34.7 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $9.66 Million - $11.2 Million
33,522 Added 44.96%
108,084 $35.9 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $1.53 Million - $2.17 Million
5,725 Added 8.32%
74,562 $22.7 Million
Q2 2019

Aug 16, 2019

BUY
$300.59 - $368.15 $15.3 Million - $18.7 Million
50,815 Added 281.96%
68,837 $25.3 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $2.21 Million - $2.71 Million
7,366 Added 69.13%
18,022 $6.64 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $2.66 Million - $3.13 Million
9,751 Added 1077.46%
10,656 $3.31 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $6.34 Million - $8.53 Million
-23,266 Reduced 96.26%
905 $271,000
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $371,688 - $475,782
1,629 Added 7.23%
24,171 $6.75 Million
Q1 2018

May 15, 2018

SELL
$209.54 - $253.91 $31.6 Million - $38.3 Million
-150,882 Reduced 87.0%
22,542 $5.33 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $3.08 Million - $3.5 Million
15,234 Added 9.63%
173,424 $37.9 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $27.3 Million - $33.8 Million
158,190
158,190 $31.5 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.